Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-2 of 2
Keywords: Therapierefraktäre AML
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Oncology
Journal:
Onkologie
Onkologie (1985) 8 (3): 181–184.
Published Online: 22 April 2009
... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Therapierefraktäre AML AMSA Etoposid Onkologie 8: 181-184(3/1985) AMSA/Etoposid (V P 16-213) Eine Phase I/II Studie bei refraktärer akuter myeloischer Leukämie IV. Hiddemann , W...
Journal Articles
Subject Area:
Oncology
W. Hiddemann, W. Achterrath, D. Urbanitz, P. Preusser, L. Balleisen, B. Kirchhof, W. Stenzinger, T. Büchner
Journal:
Onkologie
Onkologie (1984) 7 (4): 214–216.
Published Online: 21 April 2009
...W. Hiddemann; W. Achterrath; D. Urbanitz; P. Preusser; L. Balleisen; B. Kirchhof; W. Stenzinger; T. Büchner In einer Phase-I-Studie wurde die Kombination von AMSA und Etoposid bei 12 Patienten mit intensiv vorbehandelter, therapierefraktärer AML untersucht, um den für eine nachfolgende Phase-II...
